Sorrento Therapeutics, Inc. Received and Rejected Unsolicited All Cash Acquisition Proposal
25 nov. 2019 07h00 HE
|
Sorrento Therapeutics, Inc.
SAN DIEGO, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento" or the “Company”), confirmed today that on November 23, 2019, it received an unsolicited,...